Regulation, Innovation, and Access: Understanding the Evolving Landscape of Peptides

Podcast: Ageless Future · Regan Archibald

Opublikowano: 2026-05-06

In this session, Regan Archibald explores recent regulatory changes affecting peptides and what they could mean for clinicians, patients, and compounding pharmacies. He outlines how shifting FDA classifications may influence access to certain compounds while highlighting the broader tension between innovation, safety oversight, and pharmaceutical economics. The discussion also provides an overview of several commonly discussed peptides, explaining their origins as naturally occurring or derived molecules and their growing interest within personalized approaches to health. Throughout, Archibald emphasizes the importance of quality sourcing, regulatory awareness, and individualized strategies, framing the current moment as part of a larger transformation in how...